Skip to Main

Sit in on a conversation with BCG pharma leaders as they discuss advancing drug development with new tools, real-world data, digitization, and collaboration across cross-functional teams.

Myrto Lee is a core member of Boston Consulting Group’s Health Care and Global Advantage practices, with a focus on research and development. She serves as the Women@BCG mentoring lead for the firm’s London, Amsterdam, and Brussels’ (LAB) offices. Myrto has over 20 years of experience, including 12 years in the pharmaceutical, biotechnology, and pharmacy industries.

Myrto focuses on research and development (R&D) including regulatory, market access, and medical, across pharmaceuticals and life sciences. She is a UK-registered pharmacist and a member of TOPRA (a regulatory affairs professional body). Myrto has led several projects in R&D strategy and operating model development, R&D process improvement, divestitures across R&D, medical, safety, and regulatory market entry strategies and innovative pricing schemes.

Before joining the firm, Myrto was director of Pharmaceuticals and Life Sciences at Strategy& UK. Prior to that, she worked as a senior pharmaceutical assessor with the Medicines and Healthcare Products Regulatory Agency in the UK, having had previous experience in the UK as an R&D manager at a biotech startup, Apthon Corporation, and in pharmaceutical development R&D at Pfizer.

AREAS OF EXPERTISE

EDUCATION

  • EMBA, London Business School
  • PhD, drug delivery, Cardiff University
  • BPharm, first class honors, King’s College London

Publications and Videos

" "

Biopharma’s Path to Value with Generative AI

Implementing GenAI is not easy in an industry with a complex value chain and intensive regulatory oversight. Companies will wrestle with both choice and complexity.
Female scientist looking through microscope

Towards a Healthier, Wealthier UK: Unlocking the Value of Healthcare Data

The UK has a unique opportunity to ease the pressure on its economy and health system by unlocking the value of its unparalleled healthcare data. Learn more.

The Changing Role of Medical Affairs in Biopharma

Myrto Lee, a managing director and partner at BCG, talked with Sunil Verma, head of medical oncology at AstraZeneca, and Michael Norton, a BCG senior advisor, about how biopharma companies can use the medical affairs function to improve health outcomes for a more diverse set of patients.

what-do-patients-want-and-is-pharma-delivering-rectangle-tcm9-249166.jpg

What Do Patients Want, and Is Pharma Delivering?

A new global survey reveals patient priorities around engagement, innovation and impact, and how pharma companies can benefit by becoming more patient centric.
whats-up-with-pharma-artwork-and-labelling-1694x950-tcm9-238581.jpg

What’s Up with Pharma Artwork and Labelling?

These are exciting and challenging times for pharma’s artwork and labelling teams. Even as digital technologies are beginning to change the way the industry works, artwork and labelling teams must continue to handle frequent and extensive changes in leaflets and packaging. And pharma companies must manage more markets than ever before, including emerging markets.
biopharma-countdown-brexit-2880x1620-tcm9-196496.jpg

Biopharma’s Countdown to Brexit

As the deadline approaches and many details remain unclear, companies are left with no choice but to plan for a hard Brexit in March 2019. Here’s how to get ready.